Subcutaneous implantable cardioverter defibrillator (ICD)

Wagner G, Glechner A
Record ID 32018000319
English
Authors' objectives: Cardiovascular disease is a major public health issue accounting for almost 17 million deaths per year globally. According to estimates, 40-50% of them are sudden cardiac deaths. Approximately six million sudden cardiac deaths are caused by ventricular tachyarrhythmias. Several underlying acquired or congenital cardiac conditions are associated with an increased risk of ventricular arrhythmias. The implantable cardioverter-defibrillator (ICD) device detects and terminates these life-threatening ventricular tachyarrhythmias.
Authors' results and conclusions: Results from seven observational studies and one systematic review are insufficient to make conclusions about the comparative effectiveness of subcutaneous and transvenous ICDs. These studies, however, indicate a substantially lower risk for lead complications in patients treated with subcutaneous ICD.
Details
Project Status: Completed
URL for project: https://aihta.at/page/bewertung-medizinischer-einzelleistungen-mel-2018/en
Year Published: 2018
URL for published report: http://eprints.aihta.at/1169/1/DSD_109.pdf
URL for additional information: http://eprints.aihta.at/1169/
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Defibrillators, Implantable
  • Therapeutics
  • Surgical Procedures, Operative
  • Minimally Invasive Surgical Procedures
  • Cardiovascular System
  • Tachycardia
  • Death, Sudden, Cardiac
  • Cardiovascular Diseases
Keywords
  • Sudden cardiac death
  • ventricular tachyarrhythmia
  • implantable cardioverter-defibrillator (ICD)
  • subcutaneous ICD
  • transvenous single- or dual-chamber ICD
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.